Search - tctmd.com

Displaying 141 - 160 of 427

Sort: Relevancy | Date

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

Podcast TCTMD Talking Points

Episode 30: PARTNER 2 Quality of Life

September 20, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Daily News

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

Michael O'Riordan

July 17, 2017

News Daily News

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

L.A. McKeown

July 14, 2017

News Daily News

Incidental Findings on CT Angiography Predict All-Cause Mortality Following TAVR

Alison Palkhivala

July 07, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Presenter: David J. Cohen, Jeffrey J. Popma, Vinod H. Thourani

June 16, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Shelley Wood

May 02, 2017

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

Shelley Wood

March 17, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Daily News

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Todd Neale

February 06, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

News Daily News

Closer Look at SAVR Patients in PARTNER 2A Reveals a Quarter Also Had Additional Surgeries

Shelley Wood

January 27, 2017

Advertisement

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Episode 30: PARTNER 2 Quality of Life

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

Incidental Findings on CT Angiography Predict All-Cause Mortality Following TAVR

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

More Early Stroke With SAVR Than TAVR in SURTAVI

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Live From Washington: ACC 2017, Day One

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Closer Look at SAVR Patients in PARTNER 2A Reveals a Quarter Also Had Additional Surgeries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content